Mylan Laboratories Limited

Hemant Malhari Mande

Ramakoteswara Rao Jetti

Anjaneyaraju Indukuri

Vijaya Krishna Ravi

Neelima Bhagavatula

Amit Kumar Singh

Veera Venkata Satya Surya Appala Gosula

Nagaraju Gottumukkala

Narasimha Murty Pilli

Rajesh Joshi

Ravi Venkata Naga Vikas Chandra Dev

Anil Kumar Tripathi

Bommareddy Aggiramireddy

Umasankara Sastry Tummalapalli

Kiran Pokharkar

Narasimha Murthy Pilli

Soumyajit Ghosh

Chandrakant Chaudhri

Attanti Veera Venkata Srinivasarao

The present disclosure relates to crystalline forms of venetoclax and process for their preparation. The present disclosure also relates to process for preparation of amorphous venetoclax.

Polymorphic forms of VENCLEXTA

The present disclosure provides novel crystalline sofosbuvir form-M3 and a process for the preparation of sofosbuvir form-M3. The crystalline sofosbuvir form-M3 disclosed herein may be useful in the formulation of pharmaceutical dosage forms.

Polymorphic forms of sofosbuvir

The present disclosure provides amorphous lumacaftor, amorphous solid dispersions of lumacaftor, crystalline lumacaftor acetic acid solvate, crystalline lumacaftor ethyl acetate solvate, and processes for the preparation thereof. The lumacaftor forms disclosed herein may be useful for the preparation of oral dosage forms for treating cystic fibrosis transmembrane conductance regulator (CFTR) mediated diseases.

Forms of lumacaftor and processes for the preparation thereof

Growing community of inventors

Hyderabad Telangana, India

Hemant Malhari Mande